Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • AgroTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • Sales (& Marketing) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Advertising • Impact • Material Science • Medical Devices (& Hospital Services) • Robotics • Healthcare (& Wellness) • Investment Management • LegalTech • Mobile • Mobility • Nanotechnology • Pharmaceutical (& Medicine) • Woman Focused • Productivity |
Stages | Seed, Startup, Early Stage, Expansion, Later Stage, PIPE, Series A, Series B, Pre-seed |
Investing | United States • United Kingdom |
Investment Range | $1,300,000 - $2,000,000 |
Investment Sweet Spot | $1,600,000 |
Parkwalk Advisors is a venture capital investment management firm located in London, United Kingdom, with a focus on equity investment opportunities. Founded in 2009, they primarily target technology companies emerging from UK universities and similar research institutions. They are known for their significant involvement in the technology ecosystem, particularly for investing in sectors such as healthcare, energy, materials, technology, application software, and digital media. In 2017, Parkwalk became part of the IP Group plc, further enhancing its capabilities and reach within the investment community. Their investment thesis revolves around backing innovative technologies with the potential to impact strategic sectors important to the UK economy, such as AI, big data, life science, cleantech, future mobility, medtech, and quantum computing. The firm provides funding to dynamic university spin-outs seeking to commercialize intellectual property and technology. With an investment portfolio that includes sectors like Biotech, AgroTech, FinTech, Hardware, Energy, Retail, CleanTech, HealthTech, Advertising, Impact, and Robotics, Parkwalk Advisors has a broad spectrum of interests. The firm has raised over £500 million and invested in more than 180 companies, with £150 million returned to investors through exits. Their investment range is typically between £1,300,000 and £2,000,000, with a 'sweet spot' of around £1,600,000. The firm's specialties cover various stages of company growth, encompassing Seed, Startup, Early Stage, Expansion, Later Stage, PIPE, Series A, and Series B investments. The Parkwalk team combines diverse skills and experience to support high-growth innovation. They emphasize the importance of conducting investments in a way that aligns with Enterprise Investment Scheme (EIS) benefits, focusing on knowledge-intensive companies. Furthermore, Parkwalk Advisors emphasizes the high-risk nature of their investments in smaller and unquoted companies, pointing out potential difficulties in valuing and disposing of such investments, and that tax reliefs depend on individual circumstances and are subject to change.